Candel Therapeutics, Inc. (CADL) stock
CADLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.32−0.08 (-1.48%)
Close on Nov 18, 2026Market cap $407.08MP/E –Yield –
Candel Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Candel Therapeutics's price to book ratio was 5.6× on Nov 11, 2026, against 3.3× a year earlier. Over the last 5 years it ranged from 0.8× to 43.7×, with a median of 3.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.6× | +1.7 |
| 2025 | Dec 31, 2025 | 3.9× | −25.2 |
| 2024 | Jul 31, 2024 | 29.1× | +27.3 |
| 2023 | Dec 29, 2023 | 1.8× | +0.9 |
| 2022 | Dec 30, 2022 | 1.0× | −2.6 |
| 2021 | Dec 31, 2021 | 3.6× | – |
See a number that looks wrong?